CHC LABS INC.
|
GAMMA GLUTAMYL TRANSFERASE (82977) |
|
|
003.1 |
Salmonella septicemia |
|
006.0-006.9 |
Acute amebic dysentery without abscess |
|
014.00-014.86 |
Tuberculous peritonitis unspecified examination |
|
017.90-017.96 |
Tuberculosis of other specified organs unspecified examination |
|
018.90-018.96 |
Unspecified miliary tuberculosis unspecified examination |
|
020.0-020.9 |
Bubonic plague |
|
022.3 |
Anthrax septicemia |
|
027.0 |
Listeriosis |
|
027.1 |
Erysipelothrix infection |
|
030.1 |
Tuberculoid leprosy (type T) |
|
032.83 |
Diphtheritic peritonitis |
|
036.1 |
Meningococcal encephalitis |
|
036.2 |
Meningococcemia |
|
038.0-038.9 |
Streptococcal septicemia |
|
039.2 |
Abdominal actinomycotic infection |
|
040.0 |
Gas gangrene |
|
042 |
Human immunodeficiency virus (HIV) disease |
|
054.0 |
Eczema herpeticum |
|
054.5 |
Herpetic septicemia |
|
060.0-060.1 |
Sylvatic yellow fever |
|
070.0-070.9 |
Viral hepatitis A with hepatic coma |
|
072.71 |
Mumps hepatitis |
|
073.0 |
Ornithosis with pneumonia |
|
074.8 |
Other specified diseases due to Coxsackie virus |
|
075 |
Infectious mononucleosis |
|
078.5 |
Cytomegaloviral disease |
|
079.99 |
Unspecified viral infection |
|
082.0-082.9 |
Spotted fevers |
|
084.9 |
Other pernicious complications of malaria |
|
086.1 |
Chagas’ disease with other organ involvement |
|
088.81 |
Lyme disease |
|
091.62 |
Secondary syphilitic hepatitis |
|
095.3 |
Syphilis of liver |
|
100.0 |
Leptospirosis icterohemorrhagica |
|
112.5 |
Disseminated candidiasis |
|
115.00 |
Infection by histoplasma capsulatum without manifestation |
|
120.9 |
Schistosomiasis unspecified |
|
121.1 |
Clonorchiasis |
|
121.3 |
Fascioliasis |
|
122.0 |
Echinococcus granulosus infection of liver |
|
122.5 |
Echinococcus multilocularis infection of liver |
|
122.8 |
Echinococcosis unspecified of liver |
|
122.9 |
Echinococcosis other and unspecified |
|
130.5 |
Hepatitis due to toxoplasmosis |
|
135 |
Sarcoidosis |
|
150.0-159.9 |
Malignant neoplasm of cervical esophagus |
|
160.0-165.9 |
Malignant neoplasm of nasal cavities |
|
170.0-176.9 |
Malignant neoplasm of bones of skull and face except mandible |
|
179-189.9 |
Malignant neoplasm of uterus, part unspecified |
|
272.9 |
Unspecified disorder of lipoid metabolism |
|
273.4 |
Alpha-1 antitrypsin deficiency |
|
275.0 |
Disorders of iron metabolism |
|
275.1 |
Disorders of copper metabolism |
|
275.3 |
Disorders of phosphorus metabolism |
|
275.40-275.49 |
Unspecified disorder of calcium metabolism |
|
277.1 |
Disorders of porphyrin metabolism |
|
277.3 |
Amyloidosis |
|
277.4 |
Disorders of bilirubin excretion |
|
277.6 |
Other deficiencies of circulating enzymes |
|
282.60-282.69 |
Sickle-cell anemia unspecified |
|
286.6 |
Defibrination syndrome |
|
286.7 |
Acquired coagulation factor deficiency |
|
289.4 |
Hypersplenism |
|
291.0-291.9 |
Alcohol withdrawal delirium |
|
303.00-303.03 |
Acute alcoholic intoxication in alcoholism, unspecified drinking behavior |
|
303.90-303.93 |
Other and unspecified alcohol dependence, unspecified drinking behavior |
|
304.00-304.93 |
Opioid type dependence, unspecified use |
|
305.00-305.93 |
Nondependent alcohol abuse, unspecified drinking behavior |
|
357.5 |
Alcoholic polyneuropathy |
|
359.2 |
Myotonic disorders |
|
452 |
Portal vein thrombosis |
|
453.0-453.9 |
Budd-Chiari syndrome |
|
456.0-456.21 |
Esophageal varices with bleeding |
|
555.0-555.9 |
Regional enteritis of small intestine |
|
556.0-556.9 |
Ulcerative (chronic) enterocolitis |
|
557.0 |
Acute vascular insufficiency of intestine |
|
558.1-558.9 |
Gastroenteritis and colitis due to radiation |
|
560.0-560.9 |
Intussusception |
|
562.01 |
Diverticulitis of small intestine (without hemorrhage) |
|
200.00-208.91 |
Reticulosarcoma unspecified site |
|
211.5 |
Benign neoplasm of liver and biliary passages |
|
211.6 |
Benign neoplasm of pancreas except islets of Langerhans |
|
211.7 |
Benign neoplasm of islets of Langerhans |
|
228.04 |
Hemangioma of intra-abdominal structures |
|
230.7 |
Carcinoma in situ of other and unspecified parts of intestine |
|
230.8 |
Carcinoma in situ of liver and biliary system |
|
230.9 |
Carcinoma in situ of other and unspecified digestive organs |
|
235.0-238.9 |
Neoplasm of uncertain behavior of major salivary gland |
|
239.0 |
Neoplasm of unspecified nature of digestive system |
|
250.00-250.93 |
Diabetes mellitus without complication type II or unspecified type not stated as uncontrolled |
|
252.00-252.02 |
Hyperparathyroidism |
|
263.1 |
Malnutrition of mild degree |
|
263.9 |
Unspecified protein-calorie malnutrition |
|
268.0 |
Rickets active |
|
268.2 |
Osteomalacia unspecified |
|
269.0 |
Deficiency of vitamin K |
|
270.2 |
Other disturbances of aromatic amino-acid metabolism |
|
270.9 |
Unspecified disorder of amino-acid metabolism |
|
271.0 |
Glycogenosis |
|
272.0 |
Pure hypercholesterolemia |
|
272.1 |
Pure hyperglyceridemia |
272.2 Mixed hyperlipidemia
|
272.4 Other and unspecified hyperlipidemia |
|
Lipidoses |
272.7
|
562.03 |
Diverticulitis of small intestine with hemorrhage |
|
562.11 |
Diverticulitis of colon (without hemorrhage) |
|
562.13 |
Diverticulitis of colon with hemorrhage |
|
567.0 |
Peritonitis in infectious diseases classified elsewhere |
|
567.1 |
Pneumococcal peritonitis |
|
567.21 |
Peritonitis (acute) generalized |
|
567.22 |
Peritoneal abscess |
|
567.23 |
Spontaneous bacterial peritonitis |
|
567.29 |
Other suppurative peritonitis |
|
567.38 |
Other retroperitoneal abscess |
|
567.39 |
Other retroperitoneal infections |
|
567.81 |
Choleperitonitis |
|
567.82 |
Sclerosing mesenteritis |
|
567.89 |
Other specified peritonitis |
|
567.9 |
Unspecified peritonitis |
|
569.83 |
Perforation of intestine |
|
570 |
Acute and subacute necrosis of liver |
|
571.0-571.9 |
Alcoholic fatty liver |
|
572.0-572.8 |
Abscess of liver |
|
573.0-573.9 |
Chronic passive congestion of liver |
|
574.00-574.91 |
Calculus of gallbladder with acute cholecystitis without obstruction |
|
575.0-575.9 |
Acute cholecystitis |
|
576.0-576.9 |
Postcholecystectomy syndrome |
|
581.0-581.9 |
Nephrotic syndrome with lesion of proliferative glomerulonephritis |
|
582.0-582.9 |
Chronic glomerulonephritis with lesion of proliferative glomerulonephritis |
|
583.0-583.9 |
Nephritis and nephropathy not specified as acute or chronic with lesion of proliferative glomerulonephritis |
|
584.5-584.9 |
Acute renal failure with lesion of tubular necrosis |
|
585.6 |
End Stage Renal Disease |
|
586 |
Renal failure unspecified |
|
587 |
Renal sclerosis unspecified |
|
588.0-588.9 |
Renal osteodystrophy |
|
590.00-590.9 |
Chronic pyelonephritis without lesion of renal medullary necrosis |
|
642.50-642.54 |
Severe pre-eclampsia unspecified as to episode of care |
|
646.70 |
Liver disorders in pregnancy unspecified as to episode of care |
|
646.71 |
Liver disorders in pregnancy with delivery |
|
646.73 |
Antepartum liver disorders |
|
782.4 |
Jaundice unspecified, not of newborn |
|
789.1 |
Hepatomegaly |
|
790.4 |
Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase (LDH) |
|
790.5 |
Other nonspecific abnormal serum enzyme levels |
|
960.0-979.9 |
Poisoning by penicillins |
|
980.0-989.89 |
Toxic effect of ethyl alcohol |
|
V42.7 |
Liver replaced by transplant |
|
V58.61-V58.69 |
Long-term (current) use of anticoagulants |
|
V67.1 |
Follow-up examination following radiotherapy |
|
V67.2 |
Follow-up examination following chemotherapy |
|
V67.51 |
Follow-up examination following completed treatment with high-risk medication not elsewhere classified |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|